A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

• Status: Terminated
• Trial end date: 2007-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pfizer
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diabetes mellitus Type 1

Exclusion Criteria:

• Asthma, COPD

• Smoking